Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Tianyin Pharma Calls for 75% Improvement in 2011 Results

publication date: Dec 3, 2009
Tianyin Pharmaceutical, Co., a modernized TCM company, issued guidance calling for a 75% improvement in fiscal year 2011 (ending June 30, 2011) results. The company said it expects revenue of $113 million for fiscal 2011, up from $63.6 million in 2010, and net income of $19.6 million, a rise from $11.3 million in the current year. More details..
Stock Symbol: (NYSE Alternext: TPI)


Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital